Week 4 Midterm: NR566 NR-566

Week 4 Midterm: NR566 / NR-566

(Latest Update 2025 / 2026) Advanced Pharmacology for Care of the Family | Test Module Questions & Answers | 100% Correct | Grade A - Chamberlain

Question:

How to discontinue phentermine and/or topiramate

Answer:

If a patient who is taking phentermine and topiramate has not lost 5% of weight loss by six months, the drugs should be discontinued by tapering off medication.

Question:

· Topiramate Therapeutic effect

Answer:

induces sense of satiety

• / 2

Question:

· Orlistat Patient education needed

Answer:

Approximately 20% to 30% of patients experience oily rectal leakage, flatulence with discharge, fecal urgency, and fatty or oily stools. Another 10% experience increased defecation and fecal incontinence. All of these are the result of reduced fat absorption, and all can be minimized by reducing fat intake. Dosing with psyllium (Metamucil and others), a bulk-forming laxative, can greatly reduce GI effects. The underlying mechanism is adsorption of dietary fat by psyllium.

By reducing fat absorption, orlistat can reduce absorption of fat-soluble vitamins (vitamins A, D, E, and K). Vitamin K deficiency can intensify the effects of warfarin, an anticoagulant. In patients taking warfarin, anticoagulant effects should be monitored closely. To avoid deficiency, patients should take a daily multivitamin supplement. Administration should be done 2 hours before or 2 hours after taking orlistat.

Question:

Which weight loss drug(s) are associated with a suicide risk in children, adolescents, and young adults?

Answer:

Naltrexone and Bupropion (Contrave)

• / 2